405
Participants
Start Date
October 31, 2013
Primary Completion Date
May 31, 2016
Study Completion Date
October 31, 2016
ganaxolone
200 mg and 225 mg capsules; target dose 1800 mg/day dosed 900mg 2x/day
Placebo
placebo
Medical Center Excelsior 4, Sofia
SHATNP, Sofia
MHAT Lyulin Department of Neurology, Sofia
UMHAT Alexandrovska Clinic of Nerve Diseases, Sofia
The Prince of Wales Hospital, Randwick
Royal Prince Alfred Hospital, Camperdown
Westmead Hospital, Westmead
MHAT, Blagoevgrad
The Royal Melbourne Hospital, Parkville
St. Vincent's Hospital, Fitzroy
The Florey Institute of Neuroscience and Mental Health, Heidelberg
Flinders Medical Center, Bedford Park
UMHAT Dr. Georgi Stranski Clinic of Neurology, Pleven
Medical Centre-Teodora, Rousse
Medical Center Ekvita Ltd, Varna
New York University Comprehensive Epilepsy Center, New York
Northeast Regional Epilepsy Group, New York
Northeast Regional Epilepsy Group, Middletown
Winthrop University Hospital, Mineola
Five Towns Neuroscience Research, Cedarhurst
Epilepsieklinik, Bernau
Jefferson Comprehensive Epilepsy Center, Philadelphia
Temple University School of Medicine, Philadelphia
Mid-Atlantic Epilepsy Center, Bethesda
Wake Forest Health Sciences, Winston-Salem
Neuroscience Consulants, Miami
Krankenhaus Mara Epilepsie-Zentrum, Bielefeld
Medsol Clinical Research Center, Port Charlotte
Universitatsklinikum GieBen und Marburg, Marburg
University of Alabama at Birmingham, Birmingham
Neuro-Consil, Dussseldorf
Bluegrass Epilepsy Research, LLC, Lexington
Ohio State University, Columbus
Ohio Clinical Research Partners, LLC, Canton
Klinik fur Epileptologie, Bonn
Minneapolis Clinic of Neurology, Golden Valley
The Comprehensive Epilepsy Care Center for Children and Adults, Chesterfield
Clinical Trials Inc., Little Rock
Lynn Health Institute, Oklahoma City
Sooner Clinical Research, Oklahoma City
Neurology Consultants of Dallas, Dallas
Texas Epilepsy Group, Dallas
University of Colorado- Anschutz Outpatient Pavilion, Aurora
Consultants in Epilepsy & Neurology, Boise
Xenoscience Inc., Phoenix
The MORE Foundation, Sun City
Universitatsklin Kum Ulm, Ulm
Neurological Research Institute, Santa Monica
Neuro-Pain Medical Center, Inc, Fresno
Rainier Clinical Research Center, Inc., Renton
Moscow
Moscow
Yaroslavl
Saint Petersburg
Saint Petersburg
Kazan State Medical University, Kazan'
Samara
Nizhny Novgorod
Novosibirsk
City Neurological Center, Novosibirsk
University of Alabama Epilepsy Center, Birmingham
Bringham and Women's Hospital, Boston
Cooper Medical Center of Rowan University, Camden
Northeast Regional Epilepsy Group, Hackensack
Novo-Med, Jaworowa
Centrum Medycne Dendryt, Katowice
Indywidualna Praktyka ul Narutowicza, Lublin
Wojewodzki Szpital Specjalistyczny Oddzial, Lublin
Fundacja Epileptologii Wiertnicza, Warsaw
Instytut Psychiatrii i Neurologii, Warsaw
Saint Petersburg
Lead Sponsor
Marinus Pharmaceuticals
INDUSTRY